Mark Kroll

Mark W.
Kroll currently works at Haemonetics Corp., as Independent Director from 2006, Medisyn Technologies, Inc., as Director, and San Francisco Opera Association, as Director.
Dr. Kroll also formerly worked at Recombinetics, Inc., as Director, TriVirix International, Inc., as Director, NewCardio, Inc., as Director from 2011 to 2012, Ionix Medical, Inc., as Director, Axon Enterprise, Inc., as Independent Director from 2003 to 2024, MGC Diagnostics Corp., as Vice President-Research in 1995, St. Jude Medical LLC, as SVP & CTO-Cardiac Rhythm Management Division from 1995 to 2005, Vital Health Technologies, Inc., as Vice President-Research & Development in 1991, Harbinger Medical, Inc., as Secretary from 1993 to 2009, and Intercomp Co., as Vice President-Research & Development in 1985.
Dr. Kroll received his Masters Business Admin degree in 1990 from the University of St. Thomas (Texas), undergraduate degree in 1975 from College of Science & Engineering, graduate degree in 1983 from College of Science & Engineering, doctorate degree in 1987 from College of Science & Engineering, and doctorate degree from the University of Minnesota.